IgA Nephropathy - 30 Studies Found
Completed |
: The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA Nephropathy : IgA Nephropathy : 2011-10-07 : Drug: Prednisone or Prednisolone daily single dose of 1mg/kg (maximum 80mg) or alternate day single dose |
Recruiting |
: Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy : Primary IgA Nephropathy : 2016-04-30 :
|
Recruiting |
: IgA Nephropathy Biomarkers Evaluation Study (INTEREST) :
: 2016-11-02 : Other: No intervention No intervention |
Completed |
: Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of Immunoglobulin A Nephropathy : IgA Nephropathy : 2007-10-25 : Drug: Omega-3 fatty acid ethylester90 Dosage form :1g soft capsule Dosage : two capsules, twice a day. |
Completed |
: Probiotics in IgA Nephropathy : IgA Nephropathy : 2013-01-16 :
|
RECRUITING |
: Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy : IgA Nephropathy : 2024-05-16 : Period A (12 Weeks) - Film-coated tablet, Washout Period: 12 weeks, Period B (24 Weeks) - Placebo |
RECRUITING |
: A Study to Evaluate the Efficacy and Safety of RO7434656 in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression : Primary IgA Nephropathy : 2024-05-16 : RO7434656 will be administered subcutaneously per schedule as specified. |
RECRUITING |
: A Study of BION-1301 in Adults With IgA Nephropathy : IgA Nephropathy : 2024-05-16 : BION-1301 Pre-Filled Syringe (PFS) 600mg subcutaneous administration every 2 weeks for 104 weeks. |
RECRUITING |
: Atacicept in Subjects With IgA Nephropathy : IgA Nephropathy : 2024-05-16 : Once weekly subcutaneous (SC) injections by prefilled syringe |
RECRUITING |
: A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects : IgA Nephropathy : 2024-05-16 : Oral administration of specified dose of HS-10390 |